Author

N. Labiod

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Research Focus:cell-cell communication· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:proteomics· 1 Assay:spatial transcriptomics· 1

Frequent Co-Authors

F. Lasala· 2 shared J. Luczkowiak· 2 shared R. Delgado· 2 shared A. Bernardi· 1 shared C. H. Herbreteau· 1 shared C. Vives· 1 shared D. Fenel· 1 shared F. Fieschi· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 39 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

F. Lasala

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Potent Neutralizing Activity of Polyclonal Equine Antibodies against Omicron SARS-CoV-2

J. Luczkowiak, P. Radreau, L. Nguyen, N. Labiod, F. Lasala, C. H. Herbreteau, R. Delgado

This study demonstrates that equine polyclonal F(ab)2 antibodies achieve high neutralizing potency against SARS-CoV-2 variants, including Omicron, with titers up to 111,403 IU/mL.

bioRxiv · Feb 21, 2022 · PreprintMicrobiology

DC/L-SIGN recognition of spike glycoprotein promotes SARS-CoV-2 trans-infection and can be inhibited by a glycomimetic antagonist

M. Thepaut, J. Luczkowiak, C. Vives, N. Labiod, I. Bally, F. Lasala, Y. Grimoire, D. Fenel, S. Sattin, N. Thielens, G. Schoehn, A. Bernardi, R. Delgado, F. Fieschi

The paper shows DC/L-SIGN receptors on antigen-presenting cells enhance SARS-CoV-2 trans-infection, which can be blocked by a glycomimetic compound.

bioRxiv · Aug 9, 2020Immunology